Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Withdrawn 1 Unknown 1 Suspended 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Specimen Handling 15 Biopsy 9 Cyclophosphamide 8 Magnetic Resonance Spectroscopy 7 venetoclax 5 Etoposide 4 Azacitidine 4 fludarabine phosphate 3 X-Rays 3 Tacrolimus 3 Paclitaxel 3 Interleukin-2 3 Carboplatin 3 zanubrutinib 2 prednylidene 2 fludarabine 2 durvalumab 2 deltacortene 2 aldesleukin 2 Vincristine 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Protein Subunit Vaccines 2 Prednisone 2 Nivolumab 2 Melphalan 2 Injections 2 Gemcitabine 2 E 7107 2 Doxorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Suspended × Cell Count × Clear all

NCT05887882 2026-04-24

PNOC028

University of California, San Francisco

Phase 1 Suspended

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡